Lupin Secures US FDA Approval for Dapagliflozin Tablets in US
Lupin secures US FDA approval for Dapagliflozin Tablets 5 mg and 10 mg in the US, bioequivalent to Farxiga.
Lupin Pharmaceutical | 08/04/2026 | By News Bureau
Lupin Pharmaceuticals issues voluntary nationwide recall of four lots of Quinapril tabs
This is due to the potential presence of N-Nitroso-Quinapril impurity
Lupin Pharmaceutical | 22/12/2022 | By Sudeep Soparkar | 879
Lupin appoints Shahin Fesharaki as Global Chief Scientific Officer
Fesharaki will be in charge of Lupin's global R&D operations spanning branded, generic, and speciality products
Lupin Pharmaceutical | 07/10/2022 | By Sudeep Soparkar | 786
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy